AAM All Access

Today on All Access we discuss Build Back Better and its Impact on the Generic and Biosimilar Industry. My guests are Kurt Karst, Director at Hyman Phelps & McNamara, Rachel Turow, Associate General Counsel for Regulatory Law and Policy and the Head of U.S. Regulatory Policy at Teva Pharmaceuticals, and Rachel Goode, Senior Vice President for Biosimilars Patents and Legal at Fresenius Kabi.  

Today we talk with CMMB president and chief executive officer, Mary Beth Powers. With a distinct focus on women and children's health all around the world, CMMB and its global network of volunteers deliver long-term care and medicines to communities in Africa, Latin America, the Caribbean and other regions affected by poverty, and who have unequal access to healthcare. The team at CMMB is helping countless thousands of people around the world turn their personal tragedies into triumphs. 

Shortages of health care products, like the current baby formula situation, and consumer goods continue to bedevil the U.S. Yet, prescription medicines generally have been available with few disruptions since the start of the pandemic. How are drug shortages kept in check… and just what is a drug shortage, for that matter? Learn the facts by joining AAM CEO Dan Leonard as he speaks to eminent 3 pharmacists, each with different insights into management and mitigation of drug shortages: David Gaugh, SVP, Sciences & Regulatory Affairs, AAM, Jessica Daley, Group VP, Chief Pharmacy Officer, Premier, and Steven Schondelmeyer, professor of pharmacy at the University of Minnesota.

Direct Relief President and CEO Thomas Tighe joins CEO Dan Leonard to talk about the humanitarian support Direct Relief is providing at the request of Ukraine's Ministry of Health in the war-torn country and to millions of its refugees in border countries. “We're so thankful for the [generic industry's] responsiveness. They don't have to do this, it's not their job. That they did it means a lot. It means a lot for people in Ukraine.”

Today we're here in Orlando, Florida during our Annual Meeting, ACCESS! We're talking with Alok Sonig, CEO, US Generics, and Head of Global R&D & Biosimilars at Lupin Incorporated.

Our guest today is Kendra Davenport, the chief development officer for Operation Smile. Operation Smile is one of the largest volunteer surgical nonprofits in the world and an AAM member company. The team does far more than just change a child's smile, it truly transforms their life. 

Dispensary of Hope is our featured company on today's program. And joining me to talk about their efforts, their mission is Dispensary of Hope Chief Executive Officer, Mr. Chris Palombo. 

October is National Pharmacists Month. And today we have special guests who are also individuals that I'm very proud to call colleagues. At AAM, we're very proud to have three pharmacists on staff and I'm joined by two of them here today. Lisa Parks and Monét Stanford.

In celebration Hatch-Waxman's anniversary, All Access the podcast and ATS, that's Allies, Thinkers & Scribes, welcomes industry veteran and generics expert, Robert Pollock. Bob worked at FDA in the earliest days of Hatch-Waxman and was among the very first employees of the new division of generic drugs - a real pioneer in the regulatory side of our industry.

Today on All Access we speak with Doug Long, vice president of industry relations at IQVIA. IQVIA is a global leader in the use of data, technology and advanced analytics to help customers drive healthcare forward.

Our guest today is Jeff Watson, President and Chief Executive Officer of Apotex Inc. His expertise and skillful leadership is so sought after that he is the only person to have served as Chairman of the Board of Directors of both the U.S. Generic Pharmaceutical Association, the forerunner to AAM, and the Canadian Generic Pharmaceutical Association. And if that were not enough, he also has served as chair of the Healthcare Distribution Alliance's knowledge partner, the HDA Research Foundation.

Today our guest is Avik Roy, one of the most powerful speakers on the importance of competition and what real-world competition does for consumers. Avik has helped shape the national conversation on prescription drug policy. He's authored The Competition Prescription: A Market-Based Plan for Affordable Drugs, and What Medicare Can Learn from Other Countries on Drug pricing.

As we observe Independence Day 2021, our nation's 245th birthday, we want to salute our men and women in uniform. That's the theme for today's program, military veterans and their families who devoted their lives to serving our country. To help us do this and to tie it to generic medicines, of course, our guest is the honorable Anthony Principi, former Secretary of the Veterans Administration, a Vietnam War combat veteran who served as a Lieutenant Commander in the US Navy. 

Our guest today is industry veteran Bob Billings. Active in the pharmaceutical industry for more than 25 years, Bob held various positions at the Generic Pharmaceutical Association (now the Association for Accessible Medicines) from 2007 through June 2015, including Interim President and Executive Director.

Our guest today is Vinita Gupta, Chief Executive Officer of Lupin Limited, and Chair of Lupin Inc. and its subsidiary Lupin Pharmaceuticals Inc. Vinita set up Lupin Pharmaceuticals Inc. in the U.S and Europe and was instrumental in formulating and executing strategies that helped Lupin emerge as a global pharmaceutical player. Among her many accomplishments, Vinita founded, led and established Lupin's largest region, the United States.